<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta charset="utf-8"><meta http-equiv="X-UA-Compatible" content="IE=edge"><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><meta name="description" content="The gsdmvn package will eventually be incorporated into the gsDesign2 package.
This version is for the Regulatory/ASA Biopharmaceutical Subsection training course in September, 2020
The package computes the asymptotic normal distribution for group sequential designs,
generalizing the theory presented by Jennison and Turnbull (2000) to cases with
non-homogeneous treatment effect over time.
The primary application for this is group sequential design under the assumption of non-proportional hazards.
The gsdmvn package has 4 types of functions
support for asymptotic normal distribution computation,
support for group sequential bound derivation, and
support for design and power calculations.
applications to designs for survival analysis under non-proportional hazards assumptions.

"><title>gsdmvn: A package for group sequential design under non-proportional hazards (NPH) — gsdmvn • gsdmvn</title><script src="../deps/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><link href="../deps/bootstrap-5.1.3/bootstrap.min.css" rel="stylesheet"><script src="../deps/bootstrap-5.1.3/bootstrap.bundle.min.js"></script><!-- Font Awesome icons --><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/all.min.css" integrity="sha256-mmgLkCYLUQbXn0B1SRqzHar6dCnv9oZFPEC1g1cwlkk=" crossorigin="anonymous"><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/v4-shims.min.css" integrity="sha256-wZjR52fzng1pJHwx4aV2AO3yyTOXrcDW7jBpJtTwVxw=" crossorigin="anonymous"><!-- bootstrap-toc --><script src="https://cdn.rawgit.com/afeld/bootstrap-toc/v1.0.1/dist/bootstrap-toc.min.js"></script><!-- headroom.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/headroom.min.js" integrity="sha256-AsUX4SJE1+yuDu5+mAVzJbuYNPHj/WroHuZ8Ir/CkE0=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/jQuery.headroom.min.js" integrity="sha256-ZX/yNShbjqsohH1k95liqY9Gd8uOiE1S4vZc+9KQ1K4=" crossorigin="anonymous"></script><!-- clipboard.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><!-- search --><script src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/6.4.6/fuse.js" integrity="sha512-zv6Ywkjyktsohkbp9bb45V6tEMoWhzFzXis+LrMehmJZZSys19Yxf1dopHx7WzIKxr5tK2dVcYmaCk2uqdjF4A==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/autocomplete.js/0.38.0/autocomplete.jquery.min.js" integrity="sha512-GU9ayf+66Xx2TmpxqJpliWbT5PiGYxpaG8rfnBEk1LL8l1KGkRShhngwdXK1UgqhAzWpZHSiYPc09/NwDQIGyg==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/mark.min.js" integrity="sha512-5CYOlHXGh6QpOFA/TeTylKLWfB3ftPsde7AnmhuitiTX4K5SqCLBeKro6sPS8ilsz1Q4NRx3v8Ko2IBiszzdww==" crossorigin="anonymous"></script><!-- pkgdown --><script src="../pkgdown.js"></script><link href="../extra.css" rel="stylesheet"><meta property="og:title" content="gsdmvn: A package for group sequential design under non-proportional hazards (NPH) — gsdmvn"><meta property="og:description" content="The gsdmvn package will eventually be incorporated into the gsDesign2 package.
This version is for the Regulatory/ASA Biopharmaceutical Subsection training course in September, 2020
The package computes the asymptotic normal distribution for group sequential designs,
generalizing the theory presented by Jennison and Turnbull (2000) to cases with
non-homogeneous treatment effect over time.
The primary application for this is group sequential design under the assumption of non-proportional hazards.
The gsdmvn package has 4 types of functions
support for asymptotic normal distribution computation,
support for group sequential bound derivation, and
support for design and power calculations.
applications to designs for survival analysis under non-proportional hazards assumptions.

"><!-- mathjax --><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js" integrity="sha256-nvJJv9wWKEm88qvoQl9ekL2J+k/RWIsaSScxxlsrv8k=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/config/TeX-AMS-MML_HTMLorMML.js" integrity="sha256-84DKXVJXs0/F8OTMzX4UR909+jtl4G7SPypPavF+GfA=" crossorigin="anonymous"></script><!--[if lt IE 9]>
<script src="https://oss.maxcdn.com/html5shiv/3.7.3/html5shiv.min.js"></script>
<script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
<![endif]--></head><body>
    <a href="#main" class="visually-hidden-focusable">Skip to contents</a>
    

    <nav class="navbar fixed-top navbar-light navbar-expand-lg bg-light"><div class="container">
    
    <a class="navbar-brand me-2" href="../index.html">gsdmvn</a>

    <small class="nav-text text-muted me-auto" data-bs-toggle="tooltip" data-bs-placement="bottom" title="">0.2.0</small>

    
    <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbar" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
      <span class="navbar-toggler-icon"></span>
    </button>

    <div id="navbar" class="collapse navbar-collapse ms-3">
      <ul class="navbar-nav me-auto"><li class="active nav-item">
  <a class="nav-link" href="../reference/index.html">Reference</a>
</li>
<li class="nav-item dropdown">
  <a href="#" class="nav-link dropdown-toggle" data-bs-toggle="dropdown" role="button" aria-expanded="false" aria-haspopup="true" id="dropdown-articles">Articles</a>
  <div class="dropdown-menu" aria-labelledby="dropdown-articles">
    <a class="dropdown-item" href="../articles/DesignWithAverageHazardRatio.html">Design Using Average Hazard Ratio</a>
    <a class="dropdown-item" href="../articles/DesignWithSpending.html">Trial design with spending under NPH</a>
    <a class="dropdown-item" href="../articles/NPEbackground.html">Non-Proportional Effect Size in Group Sequential Design</a>
    <a class="dropdown-item" href="../articles/NPEbounds.html">Computing Bounds Under Non-Constant Treatment Effect</a>
    <a class="dropdown-item" href="../articles/PowerEvaluationWithSpending.html">Power Evaluation with Spending bounds</a>
    <a class="dropdown-item" href="../articles/QuickStart.html">Quick Start for NPH Sample Size and Power</a>
    <a class="dropdown-item" href="../articles/SpendingTimeExamples.html">Spending Time Examples</a>
  </div>
</li>
<li class="nav-item">
  <a class="nav-link" href="../news/index.html">Changelog</a>
</li>
      </ul><form class="form-inline my-2 my-lg-0" role="search">
        <input type="search" class="form-control me-sm-2" aria-label="Toggle navigation" name="search-input" data-search-index="../search.json" id="search-input" placeholder="Search for" autocomplete="off"></form>

      <ul class="navbar-nav"><li class="nav-item">
  <a class="external-link nav-link" href="https://github.com/Merck/gsdmvn/" aria-label="github">
    <span class="fab fa fab fa-github fa-lg"></span>
     
  </a>
</li>
      </ul></div>

    
  </div>
</nav><div class="container template-reference-topic">
<div class="row">
  <main id="main" class="col-md-9"><div class="page-header">
      <img src="" class="logo" alt=""><h1>gsdmvn: A package for group sequential design under non-proportional hazards (NPH)</h1>
      <small class="dont-index">Source: <a href="https://github.com/Merck/gsdmvn/blob/HEAD/R/gsdmvn.r" class="external-link"><code>R/gsdmvn.r</code></a></small>
      <div class="d-none name"><code>gsdmvn.Rd</code></div>
    </div>

    <div class="ref-description section level2">
    <p>The gsdmvn package will eventually be incorporated into the gsDesign2 package.
This version is for the Regulatory/ASA Biopharmaceutical Subsection training course in September, 2020
The package computes the asymptotic normal distribution for group sequential designs,
generalizing the theory presented by Jennison and Turnbull (2000) to cases with
non-homogeneous treatment effect over time.
The primary application for this is group sequential design under the assumption of non-proportional hazards.
The gsdmvn package has 4 types of functions</p><ol><li><p>support for asymptotic normal distribution computation,</p></li>
<li><p>support for group sequential bound derivation, and</p></li>
<li><p>support for design and power calculations.</p></li>
<li><p>applications to designs for survival analysis under non-proportional hazards assumptions.</p></li>
</ol></div>


    <div class="section level2">
    <h2 id="details">Details<a class="anchor" aria-label="anchor" href="#details"></a></h2>
    <p>In addition to the above function categeories, vignettes show how to implement</p><ol><li><p>design for a binomial endpoint as an example of how to extend the package to other endpoint types,</p></li>
<li><p>the extensive capabilities around group sequential boundary calculations,
including enabling capabilities not in the gsDesign package.</p></li>
</ol></div>
    <div class="section level2">
    <h2 id="gsdmvn-functions">gsdmvn functions<a class="anchor" aria-label="anchor" href="#gsdmvn-functions"></a></h2>
    

<p>The primary functions supporting non-proportional hazards in the short course are:</p><ul><li><p>gs_design_ahr - derive group sequential design under non-proportional hazards (NPH) for logrank test</p></li>
<li><p>gs_power_ahr - compute power for a group sequential design under non-proportional hazards for logrank test</p></li>
</ul><p>Key supportive functions specify bound derivation for designs:</p><ul><li><p>gs_b - directly provide bounds for designs</p></li>
<li><p>gs_spending_bound - provide bounds based on a spending function (e.g., Lan-DeMets O'Brien-Fleming)</p></li>
</ul><p>Underlying functions to support numerical integration that should not be directly needed by typical users are</p><ul><li><p>gridpts - set up grid points and weights for numerical integration for a normal distribution</p></li>
<li><p>h1 - initialize numerical integration grid points and weights for NPH for first analysis</p></li>
<li><p>hupdate - update numerical integration grid points and weights for NPH from one interim to the next</p></li>
<li><p>gs_power_npe - general non-constant-effect size boundary crossing probability calculation for group sequential design</p></li>
</ul></div>
    <div class="section level2">
    <h2 id="references">References<a class="anchor" aria-label="anchor" href="#references"></a></h2>
    <p>Jennison C and Turnbull BW (2000), <em>Group Sequential
Methods with Applications to Clinical Trials</em>. Boca Raton: Chapman and Hall.</p>
    </div>
    <div class="section level2">
    <h2 id="author">Author<a class="anchor" aria-label="anchor" href="#author"></a></h2>
    <p>Keaven Anderson <a href="mailto:keaven_anderson@merck.com">keaven_anderson@merck.com</a></p>
    </div>

  </main><aside class="col-md-3"><nav id="toc"><h2>On this page</h2>
    </nav></aside></div>


    <footer><div class="pkgdown-footer-left">
  <p></p><p>Developed by Keaven Anderson. Site built with <a href="https://pkgdown.r-lib.org/" class="external-link">pkgdown</a> 2.0.6. <br>Copyright © 2022 Merck &amp; Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.</p>
</div>

<div class="pkgdown-footer-right">
  <p></p><p><span></span></p>
</div>

    </footer></div>

  

  

  </body></html>

